"Biotech Publication fimaporfin Amphinex first Phase study Lancet" Drugs and Medication Database
Here are the most relevant "Biotech Publication fimaporfin Amphinex first Phase study Lancet" Drugs and Medications that we have found in our database.
More Information about "Biotech Publication fimaporfin Amphinex first Phase study Lancet" on BioPortfolio
We have published hundreds of Biotech Publication fimaporfin Amphinex first Phase study Lancet news stories on BioPortfolio along with dozens of Biotech Publication fimaporfin Amphinex first Phase study Lancet Clinical Trials and PubMed Articles about Biotech Publication fimaporfin Amphinex first Phase study Lancet for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Biotech Publication fimaporfin Amphinex first Phase study Lancet Companies in our database. You can also find out about relevant Biotech Publication fimaporfin Amphinex first Phase study Lancet Drugs and Medications on this site too.
Showing "Biotech Publication fimaporfin Amphinex first Phase study Lancet" Drugs and Medications, all 17
Carbon dioxide oxygen mixture [air liquide healthcare america corporation]
CARBON DIOXIDE OXYGEN MIXTURE COMPRESSED
Compressed gas, oxidizing, n.o.s. [air liquide healthcare america corporation]
NA
These highlights do not include all the information needed to use PRESTALIA tablets safely and effectively. See full prescribing information for PRESTALIA.PRESTALIA (perindopril arginine and amlodipine) tablets, for oral use.Initial U.S. Approval: 2015
Oral-b neutra-foam mint [oral-b laboratories]
Package. Label Principal Display Panel
Pyridostigmine bromide [rising pharmaceuticals, inc.]
Pyridostigmine Bromide Extended-Release Tablets, 180 mg
Ez-ox plus [air liquide america l.p.]
NA
Vivotif-b [rebel distributors corp]
Vivotif-B
Stelara [janssen biotech, inc.]
These highlights do not include all the information needed to use STELARA safely and effectively. See full prescribing information for STELARA. STELARA (ustekinumab) injection, for subcutaneous or intravenous use Initial U.S. Approval: 2009
Iclusig [millennium pharmaceuticals, inc.]
These highlights do not include all the information needed to use ICLUSIG safely and effectively. See full prescribing information for ICLUSIG. ICLUSIG(ponatinib) tablets, for oral use Initial U.S. Approval: 2012
CariFree® CTx4 Gel 50001.1% (w/w) sodium fluoride
Sodium fluoride f 18 [global isotopes, llc d/b/a zevacor molecular]
These highlights do not include all the information needed to use Sodium Fluoride F18 Injection safely and effectively. See full prescribing information for Sodium Fluoride F18 Injection. Sodium Fluoride F18 Injection, USP for intravenous use Initial U.S.
Tamiflu [physicians total care, inc.]
These highlights do not include all the information needed to use TAMIFLU safely and effectively. See full prescribing information for TAMIFLU. TAMIFLU (oseltamivir phosphate) capsules TAMIFLU (oseltamivir phosphate) for oral suspension Initial U.S. Appro
Tamiflu [rebel distributors corp]
These highlights do not include all the information needed to use TAMIFLU safely and effectively. See full prescribing information for TAMIFLU. TAMIFLU (oseltamivir phosphate) capsules TAMIFLU (oseltamivir phosphate) for oral suspension Initial U.S. Appro
Reopro [janssen biotech, inc.]
ReoPro Abciximab
Simponi aria [janssen biotech, inc.]
These highlights do not include all the information needed to use SIMPONI ARIA safely and effectively. See full prescribing information for SIMPONI ARIA. SIMPONI ARIA (golimumab) injection, for intravenous use Initial U.S. Approval: 2009
Sodium fluoride f 18 [spectron mrc, llc]
Sodium Fluoride F 18 Injection HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use Sodium Fluoride F 18 Injection safely and effectively. See full prescribing information for Sodium Fluoride F 18 Injecti
Tremfya [janssen biotech, inc.]
These highlights do not include all the information needed to use TREMFYA safely and effectively. See full prescribing information for TREMFYA. TREMFYA (guselkumab) injection, for subcutaneous use Initial U.S. Approval: 2017
